Remnant-like Lipoprotein Particles as Risk Factors for Coronary Artery Disease in Elderly Patients

Abstract

Although remnant-like lipoprotein particles (RLPs) are known to be atherogenic, the relationship between serum RLP-cholesterol (RLP-C) level and coronary artery disease (CAD) has not as yet been evaluated. This clinical study was aimed at investigating the pathological significance of serum RLP-C among several coronary risk factors with a clear focus on elderly patients. We took fasting venous blood samples to determine lipid profiles including RLP-C from 188 patients with angiographically identified CAD and 68 control patients. Overall analysis showed that the RLP-C/HDL-C ratio was higher in both single-vessel CAD group (n = 67; p < 0.01) and multi-vessel CAD group (n = 121; p < 0.001) compared to controls. Further, multiple logistic regression analysis indicated that the diabetes, HDL-C and the RLP-C/HDL-C ratio could discriminate CAD patients from controls. In patients younger than 65 years, diabetes, HDL-C, LDL-C and the LDL-C/HDL-C ratio as well as the RLP-C/HDL-C ratio could discriminate CAD. In patients 65 aged years or older, however, diabetes, triglyceride and RLP-C as well as the RLP-C/HDL-C ratio could discriminate CAD, whereas LDL-C and the LDL-C/HDL-C ratio could not. These results led us to believe that the contribution of a given risk factor to the development of CAD in elderly patients may be different from that in younger patients. In elderly patients, RLP-C rather than LDL-C was strongly associated with the development of CAD. Accordingly, serum RLP-C levels may serve as a convenient and reliable index for assessing CAD.

Remnant-like lipoprotein particles - Coronary artery disease - RLP-cholesterol - Risk factor - Elderly patients

References

• 1 Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.  Circulation. 1981;  64 1174-1184
• 2 Phillips N R, Waters D, Havel R J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.  Circulation. 1993;  88 2762-2770
• 3 Kameda K, Matsuzawa Y, Kubo M, Ishikawa K, Maejima I, Yamamura T, Yamamoto A, Tarui S. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.  Atherosclerosis. 1984;  51 241-249
• 4 Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.  Circulation. 1987;  75 124-130
• 5 Krauss R M, Lindgren F T, Williams P T, Kelsey S F, Brensike J, Vranizan K, Detre K M, Levy R I. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.  Lancet. 1987;  2 62-66
• 6 Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M. et al . Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.  Clinica Chimica Acta. 1993;  223 53-71
• 7 Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H. et al . Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.  Circulation. 1998;  97 2519-2526
• 8 Inoue T, Saniabadi A R, Matsunaga R, Hoshi K, Yaguchi I, Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles.  Atherosclerosis. 1998;  139 363-367
• 9 Masuoka H, Ishikura K, Kamei S, Obe T, Seko T, Okuda K. et al . Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease.  Am Heart J. 1998;  136 226-230
• 10 Campos E, Nakajima K, Tanaka A, Havel R J. Properties of an apo E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.  J Lipid Res. 1992;  33 369-380
• 11 Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M. et al . A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay.  J Atheroscler Thromb. 1994;  1 30-36
• 12 Wilson P W, D’Agostino R B, Levy D, Belanger A M, Silbershatz H, Kannel W B. Prediction of coronary heart disease using risk factor categories.  Circulation. 1998;  97 1837-1847
• 13 Higashi K, Ito T, Nakajima K, Yonemura A, Nakamura H, Ohsuzu F. Remnant-like particles cholesterol is higher in diabetic patients with coronary artery disease.  Metabolism. 2001;  50 1462-1465
• 14 Witztum J L, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis.  J Clin Invest. 1991;  88 1785-1792
• 15 Silverman K J, Grossman W. Angina pectoris: Natural history and strategies for evaluation and management.  N Engl J Med. 1984;  310 1712-1717
• 16 Cashin-Hemphil L, Mark W J, Pogoda J M, Sanmarco M E, Azen S P, Blankenhorn D H. Beneficial effects of colestipol-niacin on coronary atherosclerosis : A 4-year follow up.  JAMA. 1990;  323 1289-1298
• 17 Weisgraber K H. Apolipoprotein E: structure-function relationships.  Adv Protein. Chem1995;  45 249-302
• 18 Mahley R W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology.  Science. 1988;  240 622-630